Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Idhifa

(ide-HEE-fuh)
A drug used to treat adults with acute myeloid leukemia that has come back or has not gotten better with other treatment. It is used in patients whose cancer has a mutation (change) in the IDH2 gene. It is also being studied in the treatment of other types of cancer. Idhifa blocks the protein made by the mutated IDH2 gene. Blocking this protein may help keep cancer cells from growing. Idhifa is a type of enzyme inhibitor. Also called enasidenib mesylate.
More Information
Search NCI's Dictionary of Cancer Terms